Business Wire

Yunmai Just Launched a #YunmaiAthletes Community Campaign

Share

The leading wellness equipment brand Yunmai is announcing the #YunmaiAthletes community campaign. Yunmai serves professional players across different sports by supporting them with professional, effective, and portable muscle recovery solutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220718005331/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Yunmai Just Launched a #YunmaiAthletes Community Campaign (Photo: Business Wire)

In April 2021, Yunmai announced its first Global Brand Ambassador, Ansu Fati, the "New No. 10" from FC Barcelona, who inherited the number from Lionel Messi, for its line of massage guns. “Join Yunmai Athletes, enter a new dimension, and achieve your peak athletic performance,” said Ansu Fati. At the young age of 17 years, Fati had already set athletic world records that made him the obvious choice to represent Yunmai on a global stage.

Yunmai‘s products are designed to empower sports enthusiasts and especially professional athletes to fully control their fitness and wellness. For many athletes, Yunmai massage guns have been part of their daily training routine to enhance their performance during competitions. In addition to Ansu Fati, the world’s No. 1 Badminton player Viktor Axelsen, who has won two Olympic medals, favors his Yunmai Massage Gun Pro Basic: “To keep my training session challenging, it's essential to have Yunmai relaxation gadgets at my disposal.”

Three-time Olympic gold medalist Kaillie Humphries also approves of the powerful Yunmai Massage Gun Slim Chic: “Whether I'm warming up before lifting or cooling down after a competition, the Yunmai massage gun helps me recover faster.” Humphries’ hard training and winning moments on the field are enabled by Yunmai’s high-quality percussive therapy devices to improve her pre-workout activation and post-workout muscle recovery.

Yunmai is dedicated to help users “Simplify Your Workout” and unlock the best version of themselves with quick warm-ups, instant recovery, and precise data tracking. “I love how Yunmai lets me take control of recovery in a simple and efficient way,” explained Joey Haywood, the streetball legend from Canada.

Yunmai specializes in technology-driven massage guns, smart scales, and smart jump ropes, which are sold in over 115 countries today. Yunmai’s award-winning products have been featured in a wide range of well-known global media outlets, including CNN, Forbes, Rolling Stone, and the Wall Street Journal.

About Yunmai

The sports and fitness brand Yunmai has been using technology and innovation to enhance workouts since 2014. Yunmai pioneered the manufacturing of smart scales and continues to innovate in the smart health market.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Yunmai
Carlos Xie
hi@iyunmai.com
www.yunmaiglobal.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

European Commission Approves Celltrion Healthcare’s Vegzelma™ (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer19.8.2022 04:47:00 CEST | Press release

Celltrion Healthcare announced today that the European Commission (EC) has approved Vegzelma™ (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin®, for the treatment of metastatic breast cancer, non-small cell lung cancer, advanced and/or metastatic renal cell cancer, metastatic carcinoma of the colon or rectum, ovarian cancer and cervical cancer. “The European Commission’s approval of Vegzelma™ will increase access to treatment for patients living with certain types of cancer at an affordable price,” said Kevin Byoung Seo Choi, Senior Vice President and Head of Marketing Division at Celltrion Healthcare. “With proven similarities in efficacy and safety compared to the reference product Avastin®, Vegzelma™ will be available to treat some of the most commonly diagnosed cancers, which collectively affect hundreds of thousands of European patients each year.” The EC approval of Vegzelma™ follows the recommendation for marketing authorisation issued by the Committee for Medi

Dermaliq Therapeutics announces first patient dosed in Phase 1b/2 trial evaluating DLQ02 for treatment of plaque psoriasis18.8.2022 18:27:00 CEST | Press release

Dermaliq Therapeutics, Inc. (Dermaliq), a private, clinical stage pharmaceutical company with a focus on dermatology, today announced first patient dosed in a Phase 1b/2a trial with DLQ02, a topical calcineurin inhibitor. The trial is designed to evaluate the safety, systemic absorption, pharmacodynamics, and clinical efficacy of DLQ02 in patients with plaque psoriasis. “DLQ02 evaluates for the first time hyliQTM, a novel platform technology in dermatology to create best in-class topical therapies with superior bioavailability,” said Betsy Hughes-Formella, PhD, Chief Scientific Officer at Dermaliq. “Calcineurin inhibitors for the treatment of psoriasis are a standard of care when given orally, albeit being associated with significant risk for systemic side effects. DLQ02 is designed to overcome the challenges of topical delivery of this drug class with reduced risk profiles. We are convinced DLQ02 has the potential to transform topical psoriasis therapy for millions of patients.” The r

Aero Secures $65M in Series B Financing to Accelerate the Future of Premium Air Travel18.8.2022 18:00:00 CEST | Press release

Aero Technologies, Inc. the next-generation premium air travel company, which serves routes in both the US and Europe, today announced a $65M capital raise, $50M in Series B funding and $15M in convertible notes, for a total post-money valuation of $300M. The funding round was co-led by AlbaCore Capital Group, one of Europe’s leading alternative investment firms, and returning investors Expa and Keyframe Capital, with new investment from Capital One Ventures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220818005095/en/ (Photo: Business Wire) Inspired by the golden age of aviation and designed for modern life, Aero is redefining semi-private air travel. Aero serves premium leisure travelers through private terminals, enriching the experience with personalized Concierge services - from booking to touchdown. With its fleet of sleek, black planes, Aero offers elevated, effortless guest experiences to curated destinations with

Veristat is Recognized on the 2022 Inc. 5000 List of America’s Fastest-Growing Private Companies18.8.2022 15:49:00 CEST | Press release

Veristat, global experts in clinical development, registration and post-marketing solutions proudly announces its recognition once again by Inc. Magazine as one of the 5000 fastest-growing private companies in the United States. Since its first appearance on the list in 2015, Veristat has significantly expanded in size, geographic reach and service offering to swiftly guide novel therapies through their clinical development process to regulatory approval and commercialization. Veristat’s team of scientific experts works collaboratively with clients in the biotech and pharmaceutical industries to overcome the many challenges associated with bringing to market products that address current medical shortcomings and maintain their good standing. “Being recognized as one of America’s Fastest-Growing Private Companies is a testament to Veristat’s ability to deliver innovative solutions, bold thinking and versatile engagement models to our clients,” stated Patrick Flanagan, Chief Executive Of

Methane Electrolysis Can Decarbonize LNG/LPG Imports and Achieve EU’s Climate Targets18.8.2022 14:00:00 CEST | Press release

To become independent of Russian natural gas imports by 2027, the European Union is increasing near-term imports of US or Azerbaijan liquefied natural gas (LNG) or liquefied petroleum gas (LPG). The main element of LNG, methane, is the second leading greenhouse gas contributing to climate change. Environmental organizations warn that long-term supply contracts for the fossil LNG will undermine the European Green Deal. The German company Graforce has developed a methane electrolysis technology (plasmalysis) that uses LNG or LPG to produce hydrogen and solid carbon for dioxide-free energy generation. Compared to water electrolysis, plasmalysis requires only one fifth the energy to produce the same amount of hydrogen. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220818005013/en/ Graforce has developed methane electrolysis plants. Errected at LNG terminals or other decentralized locations, they can decarbonize energy supply, a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom